Live Quote · OTCLYRAHealthcare· Biotechnology

Lyra Therapeutics, Inc.

$0.03▲ 0.00%(+$0.00)
MKT CAP $53.25KNEXT EARNINGS Nov 23, 2026
50%
Bullish
TickerSpark Score
46/100
▌ Weak
73
Valuation
60
Profitability
10
Growth
56
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LYRA research report →

Analyst Price Target
$0.50+1566.7% vs. today

Range $0.5 – $0.5

Analyst RatingHold
2 Buy3 Hold0 Sell

Price Chart

-99.04% · this period
$4.50$2.25$0.00Nov 20May 26Nov 20
52-Week Range1% of range
Low
$0.00
Current
$0.03
High
$4.59